Population Trends and Long-term Outlook for Oropharyngeal Cancer-Reference-Cited by-同舟云学术

Population Trends and Long-term Outlook for Oropharyngeal Cancer

Published:2022-02-01 Issue:2 Volume:148 Page:97
ISSN:2168-6181
Container-title:JAMA Otolaryngology–Head & Neck Surgery
language:en
Short-container-title:JAMA Otolaryngol Head Neck Surg

Author:

Osazuwa-Peters Nosayaba (Nosa)¹²³,Davies Louise⁴⁵⁶

Affiliation:

1. Department of Head and Neck Surgery & Communication Sciences, Duke University School of Medicine, Durham, North Carolina

2. Duke Cancer Institute, Duke University, Durham, North Carolina

3. Editorial Board Member, JAMA Otolaryngology–Head & Neck Surgery

4. The VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, Vermont

5. Section of Otolaryngology–Head and Neck Surgery, the Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire

6. Associate Editor, JAMA Otolaryngology–Head & Neck Surgery

Publisher

American Medical Association (AMA)

Subject

Otorhinolaryngology,Surgery

Link

https://jamanetwork.com/journals/jamaotolaryngology/articlepdf/2787304/jamaotolaryngology_osazuwapeters_2021_ed_210004_1644440968.95194.pdf

Reference17 articles.

1. Human papillomavirus and rising oropharyngeal cancer incidence in the United States.;Chaturvedi;J Clin Oncol,2011

2. Survival of human papillomavirus-associated cancers: filling in the gaps.;Osazuwa-Peters;Cancer,2018

3. Expanding indications for the human papillomavirus vaccine: one small step for the prevention of head and neck cancer, but one giant leap remains.;Osazuwa-Peters;JAMA Otolaryngol Head Neck Surg,2020

4. Human papillomavirus-attributable cancers—United States, 2012-2016.;Senkomago;MMWR Morb Mortal Wkly Rep,2019

5. Oropharyngeal cancer incidence and mortality trends in all 50 states in the US, 2001-2017.;Damgacioglu;JAMA Otolaryngol Head Neck Surg

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highlights into historical and current immune interventions for cancer;International Immunopharmacology;2023-04